Abstract Details

Title The Sustained Disease Activity Free Status as a Measure of Therapeutic Response & the Long Term Impact of Immunomodulatory Treatment

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 001

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
	No disclosure on file
Galeno Rojas, MD (British Hospital. INEBA, Al Lado Del Supermercado Chino.)	No disclosure on file
	No disclosure on file
Carlos A. Vrech, MD	No disclosure on file
Sergio Lindembaum	No disclosure on file
Richard M. Ransohoff, MD (Third Rock Ventures)	Dr. Ransohoff has received personal compensation for serving as an employee of Third Rock Ventures. Dr. Ransohoff has stock in Biogen. Dr. Ransohoff has received intellectual property interests from a discovery or technology relating to health care.

��ɫ��